High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma
出版年份 2018 全文链接
标题
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma
作者
关键词
MLL2/KMT2D, Esophageal squamous cell carcinoma (ESCC), Prognosis, EMT, TGF-β/Smad
出版物
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 144, Issue 6, Pages 1025-1035
出版商
Springer Nature
发表日期
2018-03-12
DOI
10.1007/s00432-018-2625-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of PIWIL3 in primary and metastatic melanoma
- (2016) Thilo Gambichler et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifiesKMT2Das a recurrently mutated gene
- (2015) C. Christofer Juhlin et al. GENES CHROMOSOMES & CANCER
- Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
- (2015) Jiyuan Zhang et al. NATURE MEDICINE
- KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation
- (2015) Changcun Guo et al. Oncotarget
- UTX and MLL4 Coordinately Regulate Transcriptional Programs for Cell Proliferation and Invasiveness in Breast Cancer Cells
- (2014) Jae-Hwan Kim et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of genomic alterations in oesophageal squamous cell cancer
- (2014) Yongmei Song et al. NATURE
- Genetic landscape of esophageal squamous cell carcinoma
- (2014) Yi-Bo Gao et al. NATURE GENETICS
- TGF-β1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China
- (2014) Lijuan Pang et al. PLoS One
- SMAD7: a timer of tumor progression targeting TGF-β signaling
- (2014) Lingyu Luo et al. TUMOR BIOLOGY
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Epidemiology of Esophageal Cancer in Japan and China
- (2013) Yingsong Lin et al. JOURNAL OF EPIDEMIOLOGY
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases
- (2012) N Bögershausen et al. CLINICAL GENETICS
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
- (2012) Zhi Jiang Zang et al. NATURE GENETICS
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
- (2011) Yaoting Gui et al. NATURE GENETICS
- Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors
- (2010) ShuTao Zheng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- The Genetic Landscape of the Childhood Cancer Medulloblastoma
- (2010) D. W. Parsons et al. SCIENCE
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started